Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Drug Alcohol Depend ; 231: 109233, 2022 02 01.
Article in English | MEDLINE | ID: covidwho-1719616

ABSTRACT

BACKGROUND: At the start of the COVID-19 pandemic, HIV experts suggested that an increase in mental health diagnoses and substance use among people living with HIV (PLHIV) may be an unintended consequence of COVID-19 mitigation efforts (e.g., limiting social contact). We evaluated short-term trajectories in binge drinking, marijuana, and recreational drug use in a prospective cohort of PLHIV. METHODS: Data (N = 2121 PLHIV) consist of survey responses on substance use behaviors from two pre-COVID-19 (October 2018-September 2019) and one COVID-19-era (April 2020-September 2020) timepoints within the MACS/WIHS Combined Cohort Study (MWCCS). We conducted group-based trajectory models, triangulated with generalized linear mixed models, to assess changes in binge drinking, daily marijuana use, and recreational drug use at the start of the pandemic. Controlling for age and race/ethnicity, we tested whether trajectories differed by sex and early-pandemic depressive symptoms, loneliness, and social support. RESULTS: Group-based trajectory models yielded two trajectory groups for binge drinking (none vs. any), marijuana (none/infrequent vs. daily), and recreational drug use (none vs. any). Binge drinking and recreational drug use decreased at the beginning of the pandemic. Generalized linear mixed model supported these trends. Consistent with prior research, male sex and having depressive symptoms early pandemic were positively associated with each substance use outcomes. Social support was inversely associated with recreational drug use. CONCLUSIONS: Contrary to hypotheses, problematic substance use behaviors decreased from pre-pandemic to the post-pandemic follow-up in our sample of PLHIV. Ongoing surveillance is needed to assess whether this pattern persists as the pandemic continues.


Subject(s)
Binge Drinking , COVID-19 , Cannabis , HIV Infections , Substance-Related Disorders , Binge Drinking/epidemiology , Cohort Studies , HIV Infections/epidemiology , Humans , Male , Pandemics , Prospective Studies , Recreational Drug Use , SARS-CoV-2 , Substance-Related Disorders/epidemiology , United States/epidemiology
2.
J Acquir Immune Defic Syndr ; 88(5): 426-438, 2021 12 15.
Article in English | MEDLINE | ID: covidwho-1593405

ABSTRACT

OBJECTIVES: This study describes prevention behavior and psychosocial health among people living with HIV (PLHIV) and HIV-negative people during the early wave of the coronavirus disease 2019 (COVID-19) pandemic in the United States. We assessed differences by HIV status and associations between social disruption and psychosocial health. DESIGN: A cross-sectional telephone/videoconference administered survey of 3411 PLHIV and HIV-negative participants in the Multicenter AIDS Cohort Study/WIHS Combined Cohort Study (MWCCS). METHODS: An instrument combining new and validated measures was developed to assess COVID-19 prevention efforts, social disruptions (loss of employment, childcare, health insurance, and financial supports), experiences of abuse, and psychosocial health. Interviews were performed between April and June 2020. Associations between social disruptions and psychosocial health were explored using multivariable logistic regression, adjusting for sociodemographics and HIV status. RESULTS: Almost all (97.4%) participants reported COVID-19 prevention behavior; 40.1% participants reported social disruptions, and 34.3% reported health care appointment disruption. Men living with HIV were more likely than HIV-negative men to experience social disruptions (40.6% vs. 32.9%; P < 0.01), whereas HIV-negative women were more likely than women with HIV to experience social disruptions (51.1% vs. 39.8%, P < 0.001). Participants who experienced ≥2 social disruptions had significantly higher odds of depression symptoms [aOR = 1.32; 95% confidence interval (CI): 1.12 to 1.56], anxiety (aOR = 1.63; 95% CI: 1.17 to 2.27), and social support dissatisfaction (aOR = 1.81; 95% CI: 1.26 to 2.60). CONCLUSIONS: This study builds on emerging literature demonstrating the psychosocial health impact related to the COVID-19 pandemic by providing context specific to PLHIV. The ongoing pandemic requires structural and social interventions to decrease social disruption and address psychosocial health needs among the most vulnerable populations.


Subject(s)
COVID-19/epidemiology , HIV Seronegativity , HIV Seropositivity/epidemiology , HIV Seropositivity/psychology , Mental Health/statistics & numerical data , COVID-19/psychology , Cohort Studies , Cross-Sectional Studies , Female , Humans , Male , Middle Aged , Pandemics , Prevalence , United States/epidemiology
3.
Chronic Diseases and Injuries in Canada ; 41(1), 2021.
Article in French | ProQuest Central | ID: covidwho-1371078

ABSTRACT

Dans un rapport des US Centers for Disease Control and Prevention, on a signalé une augmentation du nombre d’appels aux centres antipoison relatifs à des expositions à des produits de nettoyage et de désinfection au cours des trois premiers mois de 2020 par rapport à la même période en 2019 5. Ces données rassemblent les renseignements recueillis lors des appels concernant une exposition reçus entre janvier et juin 2019 ainsi qu’entre janvier et juin 2020, en utilisant pour ces expositions la classification de l’American Association of Poison Control Centers (AAPCC), avec comme codes 200613, 200614, 200615 et 200616 pour les désinfectants pour les mains, 39282, 40280, 42281 et 77286 pour les désinfectants, 42280, 62280, 77280 et 77282 pour les agents de blanchiment, 116400 et 116401 pour le chlore gazeux et 77403 pour la chloramine gazeuse. Nous avons consulté le Comité d’éthique de la recherche (CER) de Santé Canada pour discuter de l’initiative du SCSDI et nous avons conclu qu’un examen par le CER n’était pas nécessaire étant donnée l’exigence de suppression obligatoire des cellules de données avec petits effectifs, ce qui garantit un risque minimal de ré-identification. D’après les estimations hebdomadaires, le nombre d’appels a atteint un pic pendant la semaine du 22 mars 2020, principalement chez les plus de 19 ans (figure 2) et la variation en pourcentage a diminué de manière générale après avril 2020, à l’exception des désinfectants pour les mains et de la chloramine gazeuse.

4.
Health Promot Chronic Dis Prev Can ; 41(1): 25-29, 2021 01.
Article in English, French | MEDLINE | ID: covidwho-1068229

ABSTRACT

Little is known about the use or misuse of cleaning products during the COVID-19 pandemic. We compiled data from January to June in 2019 and 2020 from Canadian poison centres, and report on calls regarding selected cleaning products and present year-overyear percentage change. There were 3408 (42%) calls related to bleaches; 2015 (25%) to hand sanitizers; 1667 (21%) to disinfectants; 949 (12%) to chlorine gas; and 148 (2%) to chloramine gas. An increase in calls occurred in conjunction with the onset of COVID-19, with the largest increase occurring in March. Timely access to Canadian poison centre data facilitated early communication of safety messaging for dissemination to the public.


The Canadian Surveillance System for Poison Information (CSSPI) led by Health Canada is a developing network of poison centres, health authorities and regulatory agencies that facilitates early detection of poisoning incidents and alerting at the national level to inform harm reduction interventions. In response to the COVID-19 pandemic, concerns were raised over the potential for misuse of cleaning products and disinfectants; the CSSPI network monitored and assessed these concerns. An overall increase in calls about select cleaning products and disinfectants occurred concurrently with the pandemic, with percentage increases for selected products as high as 400% compared to the same period in the previous year.


Le Système canadien de surveillance des données sur les intoxications (SCSDI), dirigé par Santé Canada, est un réseau en développement composé de centres antipoison, d'autorités sanitaires et d'organismes de réglementation, qui facilite la détection précoce des incidents d'empoisonnement et une alerte rapide au niveau national afin d'éclairer les interventions en matière de réduction des risques. En réponse à la pandémie de COVID-19, des préoccupations ayant émergé quant au risque de mauvaise utilisation de produits de nettoyage et de désinfectants, le SCSDI a surveillé et évalué ces préoccupations. Une augmentation globale du nombre d'appels concernant plusieurs produits de nettoyage et désinfectants a eu lieu en concomitance avec la pandémie, certaines augmentations pouvant atteindre jusqu'à 400 % pour certains produits par rapport à la même période de l'année précédente.


Subject(s)
COVID-19/epidemiology , Disinfectants/poisoning , Environmental Exposure/statistics & numerical data , Household Products/poisoning , Poison Control Centers/statistics & numerical data , Canada/epidemiology , Humans
SELECTION OF CITATIONS
SEARCH DETAIL